Citadel Advisors - ERYTECH PHARMA ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of ERYTECH PHARMA
ValueSharesWeighting
Q2 2023$12,414
+12.0%
17,006
+50.4%
0.00%
Q1 2023$11,081
-11.4%
11,307
-70.2%
0.00%
Q4 2022$12,507
+25.1%
37,889
+108.4%
0.00%
Q3 2022$10,000
-93.2%
18,181
-86.5%
0.00%
Q2 2022$148,000
-75.0%
134,992
-58.4%
0.00%
Q1 2022$591,000
-32.9%
324,573
-13.0%
0.00%
Q4 2021$881,000
+948.8%
373,125
+2461.8%
0.00%
Q3 2021$84,000
+3.7%
14,565
+28.4%
0.00%
Q1 2021$81,00011,3430.00%
Other shareholders

There were no reported owners of ERYTECH PHARMA in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ERYTECH PHARMA shareholders